Lana Medical Company (TADAWUL:9587)

Lana Medical Company Statistics

Total Valuation

TADAWUL:9587 has a market cap or net worth of SAR 162.00 million. The enterprise value is 171.05 million.

Market Cap	162.00M
Enterprise Value	171.05M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

TADAWUL:9587 has 5.40 million shares outstanding.

Current Share Class	5.40M
Shares Outstanding	5.40M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	56.80%
Owned by Institutions (%)	n/a
Float	2.33M

Valuation Ratios

The trailing PE ratio is 13.00.

PE Ratio	13.00
Forward PE	n/a
PS Ratio	1.93
PB Ratio	2.66
P/TBV Ratio	2.66
P/FCF Ratio	n/a
P/OCF Ratio	412.00
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.87, with an EV/FCF ratio of -45.90.

EV / Earnings	13.73
EV / Sales	2.03
EV / EBITDA	9.87
EV / EBIT	12.36
EV / FCF	-45.90

Financial Position

The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.25.

Current Ratio	1.87
Quick Ratio	1.47
Debt / Equity	0.25
Debt / EBITDA	1.29
Debt / FCF	-4.13
Interest Coverage	17.71

Financial Efficiency

Return on equity (ROE) is 22.70% and return on invested capital (ROIC) is 7.76%.

Return on Equity (ROE)	22.70%
Return on Assets (ROA)	5.92%
Return on Invested Capital (ROIC)	7.76%
Return on Capital Employed (ROCE)	11.78%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.94
Inventory Turnover	15.44

Taxes

In the past 12 months, TADAWUL:9587 has paid 1.16 million in taxes.

Income Tax	1.16M
Effective Tax Rate	8.51%

Stock Price Statistics

The stock price has decreased by -19.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.68%
50-Day Moving Average	34.02
200-Day Moving Average	36.28
Relative Strength Index (RSI)	40.08
Average Volume (20 Days)	6,727

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TADAWUL:9587 had revenue of SAR 84.09 million and earned 12.46 million in profits. Earnings per share was 2.31.

Revenue	84.09M
Gross Profit	24.90M
Operating Income	8.48M
Pretax Income	13.62M
Net Income	12.46M
EBITDA	11.18M
EBIT	8.48M
Earnings Per Share (EPS)	2.31

Balance Sheet

The company has 6.35 million in cash and 15.40 million in debt, giving a net cash position of -9.05 million or -1.68 per share.

Cash & Cash Equivalents	6.35M
Total Debt	15.40M
Net Cash	-9.05M
Net Cash Per Share	-1.68
Equity (Book Value)	61.00M
Book Value Per Share	11.30
Working Capital	26.80M

Cash Flow

In the last 12 months, operating cash flow was 393,205 and capital expenditures -4.12 million, giving a free cash flow of -3.73 million.

Operating Cash Flow	393,205
Capital Expenditures	-4.12M
Free Cash Flow	-3.73M
FCF Per Share	-0.69

Margins

Gross margin is 29.61%, with operating and profit margins of 10.08% and 14.82%.

Gross Margin	29.61%
Operating Margin	10.08%
Pretax Margin	16.20%
Profit Margin	14.82%
EBITDA Margin	13.29%
EBIT Margin	10.08%
FCF Margin	n/a

Dividends & Yields

TADAWUL:9587 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7.69%
FCF Yield	-2.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 26, 2025. It was a forward split with a ratio of 1.5.

Last Split Date	Mar 26, 2025
Split Type	Forward
Split Ratio	1.5

Scores

TADAWUL:9587 has an Altman Z-Score of 3.54 and a Piotroski F-Score of 3.

Altman Z-Score	3.54
Piotroski F-Score	3